Work

Supplementary Figure S13 from Targeting AKR1B10 by Drug Repurposing with Epalrestat Overcomes Chemoresistance in Non–Small Cell Lung Cancer Patient-Derived Tumor Organoids

Year: 2024
Type: supplementary-materials
Abstract: Supplementary Figure S13. Dose titration of commonly used cytotoxic agents against LUAC (n = 6) and LUSC (n = 6) cell lines.
Language: English
Field: Medicine
Open Access status: gold
OpenAlex ID: W4402200822
Cites:
Cited by:
Related to: 10